131 related articles for article (PubMed ID: 21365817)
1. [Metformin in type 2 diabetes. An extensive observational study confirms the agent as first choice--so far].
Rydén M
Lakartidningen; 2011 Jan 26-Feb 1; 108(4):136. PubMed ID: 21365817
[No Abstract] [Full Text] [Related]
2. [Metformin role in the treatment of type 2 diabetes in 2008].
Spada A; Philippe J
Rev Med Suisse; 2008 Jun; 4(160):1392-4, 1396-7. PubMed ID: 18630062
[TBL] [Abstract][Full Text] [Related]
3. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
4. Review: metformin: potential benefits and use in chronic kidney disease.
Pilmore HL
Nephrology (Carlton); 2010 Jun; 15(4):412-8. PubMed ID: 20609092
[TBL] [Abstract][Full Text] [Related]
5. Sitagliptin/metformin (Janumet) for type 2 diabetes.
Med Lett Drugs Ther; 2007 Jun; 49(1262):45-7. PubMed ID: 17541377
[No Abstract] [Full Text] [Related]
6. [Metformin as the first line antidiabetic agent].
Svacina S
Vnitr Lek; 2010 Dec; 56(12):1225-7. PubMed ID: 21261109
[TBL] [Abstract][Full Text] [Related]
7. [Oral hypoglycemic agents and metformin in the treatment of type II non-insulin-dependent diabetes].
Isnard F
Sem Hop; 1983 Dec; 59(49):3437-8. PubMed ID: 6320423
[TBL] [Abstract][Full Text] [Related]
8. Metformin: a biguanide.
Tanja JJ; Langlass TM
Diabetes Educ; 1995; 21(6):509-10, 513-4. PubMed ID: 8549253
[TBL] [Abstract][Full Text] [Related]
9. Follow-up of intensive glucose control in type 2 diabetes.
Petrie JR
N Engl J Med; 2009 Jan; 360(4):416-7; author reply 418. PubMed ID: 19172672
[No Abstract] [Full Text] [Related]
10. Follow-up of intensive glucose control in type 2 diabetes.
Mühlhauser I
N Engl J Med; 2009 Jan; 360(4):417; author reply 418. PubMed ID: 19172674
[No Abstract] [Full Text] [Related]
11. Metformin: an alternative treatment for noninsulin-dependent diabetes mellitus.
Hitt CM
Conn Med; 1995 Dec; 59(12):727-30. PubMed ID: 8821636
[No Abstract] [Full Text] [Related]
12. Metformin reduces circulating factor VII concentrations in patients with type 2 diabetes mellitus.
Grant PJ
Thromb Haemost; 1998 Jul; 80(1):209-10. PubMed ID: 9684819
[No Abstract] [Full Text] [Related]
13. Metformin, a promising oral antihyperglycemic for the treatment of noninsulin-dependent diabetes mellitus.
Wildasin EM; Skaar DJ; Kirchain WR; Hulse M
Pharmacotherapy; 1997; 17(1):62-73. PubMed ID: 9017766
[TBL] [Abstract][Full Text] [Related]
14. Long-standing hidradenitis suppurativa treated effectively with metformin.
Arun B; Loffeld A
Clin Exp Dermatol; 2009 Dec; 34(8):920-1. PubMed ID: 19323659
[No Abstract] [Full Text] [Related]
15. [40 years of Metformin in the treatment of diabetes mellitus].
Internist (Berl); 1997 Jul; 38(7 Suppl 40 Jahre):1-8. PubMed ID: 9330653
[No Abstract] [Full Text] [Related]
16. Metformin discontinuation rate among patients with type-2 diabetes mellitus in Basrah, Iraq.
Mansour AA; Habib OS
Saudi Med J; 2007 Dec; 28(12):1919-21. PubMed ID: 18060234
[No Abstract] [Full Text] [Related]
17. Efficacy and safety of a combination of metformin and rosiglitaone in patients with type 2 diabetes mellitus--a postmarketing study.
Ballary C; Desai A
J Indian Med Assoc; 2003 Feb; 101(2):113-4, 123. PubMed ID: 12841496
[TBL] [Abstract][Full Text] [Related]
18. Current therapeutic drugs for type 2 diabetes, still useful after 50 years?
Hall GM; Nicholson G
Anesth Analg; 2009 Jun; 108(6):1727-30. PubMed ID: 19448192
[No Abstract] [Full Text] [Related]
19. Metformin: 50 years old, fit as a fiddle, and indispensable for its pivotal role in type 2 diabetes management.
Halimi S
Diabetes Metab; 2006 Dec; 32(6):555-6. PubMed ID: 17296508
[No Abstract] [Full Text] [Related]
20. Glyburide/metformin (Glucovance) for type 2 diabetes.
Med Lett Drugs Ther; 2000 Nov; 42(1092):105-6. PubMed ID: 11077467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
